Safety of Estrogens in Lupus: Birth Control Pills

PHASE3CompletedINTERVENTIONAL
Enrollment

350

Participants

Timeline

Start Date

June 30, 1997

Study Completion Date

August 31, 2003

Conditions
Systemic Lupus Erythematosus
Interventions
DRUG

Ortho-Novum 777

Trial Locations (15)

10003

Hospital for Joint Diseases, New York

10021

Hospital for Special Surgery, Dept. of Rheumatology, New York

10461

Albert Einstein College of Medicine, Jacobi Hospital, Dept. of Rheumatology, The Bronx

15213

Univ. of Pittsburgh, Dept. of Rheumatology, Pittsburgh

19104

Univ. of Pennsylvania Medical Center, Philadelphia

21205

Johns Hopkins Hospital, Dept. of Rheumatology, Baltimore

23219

Medical College of Virginia, Richmond

53226

Medical College of Wisconsin, Milwaukee

60637

University of Chicago Pritzker School of Medicine, Chicago

73104

Oklahoma Medical Research Foundation, Oklahoma City

77030

University of Texas Health Sciences Center, Houston

90024

UCLA Medical Center, Dept. of Rheumatology, Los Angeles

71130-3932

Louisiana School of Medicine, Dept. of Medicine/Immunology, Shreveport

48109-0358

Univ. of Michigan Med. Ctr., Rheumatology Division, Ann Arbor

27599-7280

UNC Medical Center, Dept. of Rheumatology, Chapel Hill

All Listed Sponsors
collaborator

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

NIH

collaborator

Office of Research on Women's Health (ORWH)

NIH

lead

NYU Langone Health

OTHER

NCT00000420 - Safety of Estrogens in Lupus: Birth Control Pills | Biotech Hunter | Biotech Hunter